Intech Biopharm Corporation (TPEX:6461)

Intech Biopharm Revenue

In the year 2025, Intech Biopharm had annual revenue of 107.53M TWD with 170.31% growth. Intech Biopharm had revenue of 4.82M in the quarter ending December 31, 2025, a decrease of -56.74%.

• Revenue: 107.53M
• Revenue Growth: +170.31%
• P/S Ratio: 28.12
• Revenue / Employee: n/a
• Employees: 90
• Market Cap: 3.02B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	107.53M	67.75M	170.31%
Dec 31, 2024	39.78M	13.93M	53.90%
Dec 31, 2023	25.85M	2.20M	9.30%
Dec 31, 2022	23.65M	-15.25M	-39.21%
Dec 31, 2021	38.90M	17.79M	84.30%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 8, 2026

Data Sources Report a data error